1994
DOI: 10.1097/00005373-199412000-00004
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Inhaled Nitric Oxide on Pulmonary Ventilation-Perfusion Matching Following Smoke Inhalation Injury

Abstract: Background: We previously reported that inhaled nitric oxide (NO) improved pulmonary function following smoke inhalation. This study evaluates the

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(11 citation statements)
references
References 0 publications
1
10
0
Order By: Relevance
“…INO has shown to be an ideal selective pulmonary vasodilator improving oxygenation and decreasing pulmonary artery pressure [123][124][125][126][127].…”
Section: Inhaled Nitric Oxidementioning
confidence: 99%
“…INO has shown to be an ideal selective pulmonary vasodilator improving oxygenation and decreasing pulmonary artery pressure [123][124][125][126][127].…”
Section: Inhaled Nitric Oxidementioning
confidence: 99%
“…In animal models, inhaled NO at concentrations of 5-80 parts per million (ppm) has been shown to produce selective and rapidly reversible pulmonary vasodilation [71,72], and in appropriate models, to improve V9/Q9 matching and increase arterial oxygenation [73][74][75]. Furthermore in experimental preparations, inhaled NO decreases both pulmonary oedema formation and neutrophil sequestration in the lung [75,76].…”
Section: Inhaled Nitric Oxidementioning
confidence: 99%
“…INO moderately improved ventilationperfusion matching and oxygenation by causing selective pulmonary vasodilation of ventilated areas in an ovine model of smoke inhalation injury [5]. This left open the question of whether INO would produce an improvement in outcome in human inhalation injury [26].…”
Section: Discussionmentioning
confidence: 99%
“…Another modality for the treatment of patients with lung failure is inhaled nitric oxide (INO), which improves perfusion of well-ventilated lung segments, and reduces pulmonary arterial hypertension [5]. Although FDA-approved for the treatment of term and near-term ( /34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension (INOmax † , INO Therapeutics, Inc., Clinton, NJ), the utility of INO as a therapy for ARDS is less well defined.…”
Section: Introductionmentioning
confidence: 99%